IONS logo

IONS
Ionis Pharmaceuticals Inc

6,661
Mkt Cap
$14.01B
Volume
1.74M
52W High
$86.74
52W Low
$23.95
PE Ratio
-50.55
IONS Fundamentals
Price
$84.79
Prev Close
$86.50
Open
$86.13
50D MA
$80.76
Beta
0.71
Avg. Volume
2.4M
EPS (Annual)
-$3.04
P/B
22.56
Rev/Employee
$659,623.95
Loading...
Loading...
News
all
press releases
Candriam S.C.A. Has $39.99 Million Stock Position in Ionis Pharmaceuticals, Inc. $IONS
Candriam S.C.A. lessened its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 15.7% during the third quarter, according to the company in its most recent Form 13F...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
Wealth Enhancement Advisory Services LLC Sells 15,476 Shares of Ionis Pharmaceuticals, Inc. $IONS
Wealth Enhancement Advisory Services LLC decreased its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 67.5% during the 3rd quarter, according to the company in its most recent...
MarketBeat·3d ago
News Placeholder
Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 1-Year High - What's Next?
Ionis Pharmaceuticals (NASDAQ:IONS) Sets New 1-Year High - What's Next...
MarketBeat·4d ago
News Placeholder
Ionis Pharmaceuticals (NASDAQ:IONS) EVP C Frank Bennett Sells 85,089 Shares
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP C Frank Bennett sold 85,089 shares of the company's stock in a transaction dated Monday, February 2nd. The shares were sold at an...
MarketBeat·5d ago
News Placeholder
C WorldWide Group Holding A S Sells 24,000 Shares of Ionis Pharmaceuticals, Inc. $IONS
C WorldWide Group Holding A S cut its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 5.3% during the 3rd quarter, according to its most recent 13F filing with the...
MarketBeat·5d ago
News Placeholder
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
GSK's Q4 earnings and sales top estimates as strong specialty medicine demand fuels growth and drives shares higher on an upbeat 2026 outlook.
Zacks·6d ago
News Placeholder
The pioneering physician behind groundbreaking ASO therapy
Dr. Stanley Crooke, founder of the n-Lorem Foundation and Ionis Pharmaceuticals, tells CNBC's Becky Quick about a gravitational moment in his work to fight rare diseases...
CNBC Television-YouTube·6d ago
News Placeholder
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Elizabeth Hougen Sells 6,988 Shares
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Elizabeth Hougen sold 6,988 shares of the firm's stock in a transaction that occurred on Friday, January 30th. The stock was sold at an...
MarketBeat·7d ago
News Placeholder
Privium Fund Management B.V. Sells 18,700 Shares of Ionis Pharmaceuticals, Inc. $IONS
Privium Fund Management B.V. lessened its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 7.0% during the third quarter, according to the company in its most recent 13F filing...
MarketBeat·10d ago
News Placeholder
Lisanti Capital Growth LLC Acquires Shares of 92,124 Ionis Pharmaceuticals, Inc. $IONS
Lisanti Capital Growth LLC bought a new position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the...
MarketBeat·10d ago
<
1
2
...
>

Latest IONS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.